Cargando…

Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection

BACKGROUND: It is well-recognized that injection of iodinated radiographic contrast media (CM) sometimes causes acute renal injury via multiple mechanisms, such as vasoconstriction, toxicity on glomerular endothelium and tubular epithelium and so forth. CASE PRESENTATION: A 51-year-old man developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Hua, Ye, Chen, Wen, Qian, Zhu, Hong-Yan, Yi, Li-Xia, Zhang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840718/
https://www.ncbi.nlm.nih.gov/pubmed/29510679
http://dx.doi.org/10.1186/s12882-018-0844-2
_version_ 1783304630090858496
author Su, Hua
Ye, Chen
Wen, Qian
Zhu, Hong-Yan
Yi, Li-Xia
Zhang, Chun
author_facet Su, Hua
Ye, Chen
Wen, Qian
Zhu, Hong-Yan
Yi, Li-Xia
Zhang, Chun
author_sort Su, Hua
collection PubMed
description BACKGROUND: It is well-recognized that injection of iodinated radiographic contrast media (CM) sometimes causes acute renal injury via multiple mechanisms, such as vasoconstriction, toxicity on glomerular endothelium and tubular epithelium and so forth. CASE PRESENTATION: A 51-year-old man developed acute renal injury with proteinuria after CM administration. To our surprise, in his renal biopsy sample the myelin figure like structure was observed in glomerular endothelium and mesangial cells by transmission electron microscopy. However the patient didn’t has any clinic clues of Fabry disease and other lysosomal storage disorders. Moreover in vitro cultured glomerular endothelial and mesangial cells we found CM triggers lipid aggregation along with the increased CD36 and decreased ABCA1 abundance. Thus this patient was administrated statin to correct the aberrant lipid trafficking, 2 months later at his next visit we found his renal function partially recovered with reduced proteinuria. CONCLUSIONS: Besides the well-known underlying mechanisms, CM may cause renal impairment by triggering the dysregulated transportation of lipid. Furthermore statin is suggested to be a very promising medicine to decrease side effects of CM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-018-0844-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5840718
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58407182018-03-09 Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection Su, Hua Ye, Chen Wen, Qian Zhu, Hong-Yan Yi, Li-Xia Zhang, Chun BMC Nephrol Case Report BACKGROUND: It is well-recognized that injection of iodinated radiographic contrast media (CM) sometimes causes acute renal injury via multiple mechanisms, such as vasoconstriction, toxicity on glomerular endothelium and tubular epithelium and so forth. CASE PRESENTATION: A 51-year-old man developed acute renal injury with proteinuria after CM administration. To our surprise, in his renal biopsy sample the myelin figure like structure was observed in glomerular endothelium and mesangial cells by transmission electron microscopy. However the patient didn’t has any clinic clues of Fabry disease and other lysosomal storage disorders. Moreover in vitro cultured glomerular endothelial and mesangial cells we found CM triggers lipid aggregation along with the increased CD36 and decreased ABCA1 abundance. Thus this patient was administrated statin to correct the aberrant lipid trafficking, 2 months later at his next visit we found his renal function partially recovered with reduced proteinuria. CONCLUSIONS: Besides the well-known underlying mechanisms, CM may cause renal impairment by triggering the dysregulated transportation of lipid. Furthermore statin is suggested to be a very promising medicine to decrease side effects of CM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-018-0844-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-06 /pmc/articles/PMC5840718/ /pubmed/29510679 http://dx.doi.org/10.1186/s12882-018-0844-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Su, Hua
Ye, Chen
Wen, Qian
Zhu, Hong-Yan
Yi, Li-Xia
Zhang, Chun
Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection
title Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection
title_full Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection
title_fullStr Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection
title_full_unstemmed Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection
title_short Case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection
title_sort case report: lipid inclusion in glomerular endothelial and mesangial cells in a patient after contrast medium injection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840718/
https://www.ncbi.nlm.nih.gov/pubmed/29510679
http://dx.doi.org/10.1186/s12882-018-0844-2
work_keys_str_mv AT suhua casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection
AT yechen casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection
AT wenqian casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection
AT zhuhongyan casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection
AT yilixia casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection
AT zhangchun casereportlipidinclusioninglomerularendothelialandmesangialcellsinapatientaftercontrastmediuminjection